Dental Devices & Distribution What the Docs Are Saying on Macro, Demand, and Innovation; Implications for HSIC, NVST, STMN, and XRAY

Research evidence excerpt

Dental Devices & Distribution What the Docs Are Saying on Macro, Demand, and Innovation; Implications for HSIC, NVST, STMN, and XRAY

ts remain more heterogeneous based on local economics,

patient demographics, and insurance participation. Independents can still be busy,

but the variability in new patient flows and reimbursement realities can create

pockets of softness that are less visible in aggregated demand data. For suppliers,

this is a market where “one-size-fits-all” selling becomes less effective, and

messaging must adapt to the operational constraints of each channel.

• DSO procurement is reinforcing standardization and trade-down behavior,

reshaping the vendor playbook. Larger groups increasingly operate through

preferred supplier frameworks, white-label adoption where appropriate, and formal

committees for larger spend decisions, which can accelerate standardization and

compress pricing where products are viewed as substitutable. At the same time,

DSOs are explicit about not compromising clinical quality, particularly in areas like

implants, where training, support, and long-term outcomes are central to provider

confidence. This creates a barbell: commoditized consumables and certain services

may see more price pressure, while premium clinical systems with service depth can

remain stickier.

• High interest rates have put a pause on discretionary equipment decisions,

turning capex into a “prove it” exercise. The consistent gating question is do you

really need it, with practices differentiating between production-driving, revenue-

producing purchases versus “nice-to-have” upgrades that may improve experience

but not output. This dynamic should structurally favor replacement demand and